NPC1 and nasopharyngeal carcinoma: However, we were limited by the fact that only NGS of the NPC1 and NPC2 genes were available at our lab, and thus we could not exclude NPC in the eight samples with elevated levels of lysoSM509 without pathogenic variants identified by NGS (Table 1, Figure 1).